Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
2,625.00
-115.00 (-4.20%)
At close: Jun 18, 2026
Korea Arlico Pharm Market Cap
Korea Arlico Pharm has a market cap or net worth of 40 billion as of June 18, 2026. Its market cap has decreased by -38.73% in one year.
Market Cap
40.00B
Enterprise Value
63.77B
Revenue
199.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,625.00
Market Cap Chart
Since February 12, 2018, Korea Arlico Pharm's market cap has decreased from 207.83B to 40.00B, a decrease of -80.75%. That is a compound annual growth rate of -17.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 40.00B | -38.95% |
| Dec 30, 2025 | 65.52B | 23.73% |
| Dec 30, 2024 | 52.95B | -39.39% |
| Dec 28, 2023 | 87.36B | -12.98% |
| Dec 29, 2022 | 100.39B | -14.71% |
| Dec 30, 2021 | 117.71B | -17.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinil Pharmaceutical | 59.27B |
| BL Pharmtech | 51.63B |
| Jin Yang Pharmaceutical | 50.03B |
| RP Bio | 45.07B |
| Eagle Veterinary Technology Co.,Ltd | 38.37B |
| GeneBioTech Co. ,Ltd | 38.32B |
| Korean Drug | 36.56B |
| Kyung Nam Pharm | 28.91B |